American journal of ophthalmology۲۰۲۶نمایه شده در PubMed
Yongyi Zhang, Gege Tang, Jingjie Zhang, Yao Fu, Xinghao Zhang, Yanhua Qi, Nan Zhou
چکیده
HER2-targeted antibody-drug conjugates (ADCs) demonstrate significant efficacy in HER2-mutated or HER2-positive tumors but may cause ocular adverse events (AEs), particularly corneal epitheliopathy and blurred vision. This study aimed to characterize the clinical features of trastuzumab botidotin…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1016/j.ajo.2026.05.028